Results 151 to 160 of about 42,435 (206)

RNA Therapeutics for Duchenne Muscular Dystrophy: Exon Skipping, RNA Editing, and Translational Insights from Genome-Edited Microminipig Models. [PDF]

Int J Mol Sci
Chassin A, Ono H, Ashida Y, Imamura M, Aoki Y.   +4 more
europepmc   +1 more source

A stochastic RNA editing process targets a select number of sites in individual <i>Drosophila</i> glutamatergic motoneurons. [PDF]

Elife
Crane AB, Inouye MO, Jetti SK, Littleton JT.   +3 more
europepmc   +1 more source

Targeted RNA base editing for therapeutic: mechanisms and advances. [PDF]

Pharm Sci Adv
Yan W, Weng X.
europepmc   +1 more source

Sharing common measures of the environment across continents: challenges and opportunities for global studies of aging. [PDF]

J Gerontol B Psychol Sci Soc Sci
Clements N, Taggart A, Keller KP, Francois K, Bravo C, Bravo D, Chaudhary E, Hunter R, Nolan A, Nichols E, Pedde M, Valson JS, Zaninotto P, Lee J, Adar SD.   +14 more
europepmc   +1 more source

The post-pandemic pivot: mRNA therapeutics enter the chronic rare disease arena. [PDF]

Mol Ther Nucleic Acids
Giangrande PH.
europepmc   +1 more source

RNA editing in cardiovascular health and disease. [PDF]

Commun Biol
Huang X, Solomon C, McVey DG, Ye S.
europepmc   +1 more source

ADARs: pleiotropy in function, versatility in application. [PDF]

Nucleic Acids Res
Zhang Y, Bryant J, Herron L, Mali P.
europepmc   +1 more source

Employing Tribe to Study RNA Interactions of Ataxin-2 in <i>Drosophila</i> S2 Cells. [PDF]

Bio Protoc
Kumar S, Koppaka O, Agrawal K, Bakthavachalu B.   +3 more
europepmc   +1 more source

Unveiling cholesterol metabolism-related gene ACOX2: a multi-omics discovery of a novel biomarker in IgA nephropathy. [PDF]

Hereditas
Deng X, Wu J, He M, Mei L, Ma L, Lin Y, Luo Y.   +6 more
europepmc   +1 more source

Dynamic and extensive A-to-I RNA recoding in immunoglobulin shapes myeloid neoplasm transcriptome. [PDF]

J Biol Chem
Cao Q, Wang Y, Duan Y.
europepmc   +1 more source